The Global Epidemiology of Hepatocellular Carcinoma, Present and Future
TLDR
The dominant effect of HBV on global HCC risk should decline as the population vaccinated against HBV grows older, and infection with HCV is also expected to decline.About:
This article is published in Clinics in Liver Disease.The article was published on 2011-05-01 and is currently open access. It has received 445 citations till now. The article focuses on the topics: Hepatitis B virus & Hepatocellular carcinoma.read more
Citations
More filters
Journal ArticleDOI
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
Masao Omata,Ann-Lii Cheng,Norihiro Kokudo,Masatoshi Kudo,Jeong Min Lee,Jidong Jia,Ryosuke Tateishi,Kwang Hyub Han,Yoghesh K. Chawla,Shuichiro Shiina,Wasim Jafri,Diana A. Payawal,Takamasa Ohki,Sadahisa Ogasawara,Pei-Jer Chen,Cosmas Rinaldi Adithya Lesmana,Laurentius A. Lesmana,Rino Alvani Gani,Shuntaro Obi,A. Kadir Dokmeci,Shiv Kumar Sarin +20 more
TL;DR: The latest guidelines for the treatment of HCC recommend evidence-based management and are considered suitable for universal use in the Asia–Pacific region, which has a diversity of medical environments.
Journal ArticleDOI
The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level : results from the Global Burden of Disease Study 2015
Tomi Akinyemiju,Semaw Ferede Abera,Semaw Ferede Abera,Muktar Beshir Ahmed,Noore Alam,Noore Alam,Mulubirhan Assefa Alemayohu,Christine Allen,Rajaa Al-Raddadi,Nelson Alvis-Guzman,Yaw Ampem Amoako,Al Artaman,Tadesse Awoke Ayele,Aleksandra Barac,Isabela M. Benseñor,Adugnaw Berhane,Zulfiqar A Bhutta,Jacqueline Castillo-Rivas,Abdulaal A Chitheer,Jee-Young Choi,Benjamin C Cowie,Lalit Dandona,Lalit Dandona,Rakhi Dandona,Rakhi Dandona,Subhojit Dey,Daniel Dicker,Huyen Do Phuc,Donatus U. Ekwueme,Maysaa El Sayed Zaki,Florian Fischer,Thomas Fürst,Thomas Fürst,Thomas Fürst,Jamie Hancock,Simon I. Hay,Peter J. Hotez,Peter J. Hotez,Sun Ha Jee,Amir Kasaeian,Yousef Khader,Young-Ho Khang,G Anil Kumar,Michael Kutz,Heidi J. Larson,Alan D. Lopez,Alan D. Lopez,Raimundas Lunevicius,Raimundas Lunevicius,Reza Malekzadeh,Colm McAlinden,Toni Meier,Walter Mendoza,Ali H. Mokdad,Maziar Moradi-Lakeh,Gabriele Nagel,Quyen Nguyen,Grant Nguyen,Felix Akpojene Ogbo,George C Patton,David M. Pereira,Farshad Pourmalek,Mostafa Qorbani,Amir Radfar,Gholamreza Roshandel,Joshua A. Salomon,Juan Sanabria,Juan Sanabria,Benn Sartorius,Maheswar Satpathy,Maheswar Satpathy,Monika Sawhney,Sadaf G. Sepanlou,Katya Anne Shackelford,Hirbo Shore,Jiandong Sun,Desalegn Tadese Mengistu,Roman Topór-Mądry,Roman Topór-Mądry,Bach Xuan Tran,Bach Xuan Tran,Kingsley N. Ukwaja,Vasiliy Victorovich Vlassov,Stein Emil Vollset,Stein Emil Vollset,Theo Vos,Tolassa Wakayo,Elisabete Weiderpass,Elisabete Weiderpass,Andrea Werdecker,Naohiro Yonemoto,Mustafa Z. Younis,Mustafa Z. Younis,Chuanhua Yu,Zoubida Zaidi,Liguo Zhu,Christopher J L Murray,Mohsen Naghavi,Christina Fitzmaurice,Christina Fitzmaurice +99 more
TL;DR: In this article, the authors report results of the Global Burden of Disease (GBD) 2015 study on primary liver cancer incidence, mortality, and disability-adjusted life-years (DALYs) for 195 countries or territories from 1990 to 2015, and present global, regional, and national estimates on the burden of liver cancer attributable to hepatitis B virus (HBV) and hepatitis C virus (HCV) infection and alcohol, and an “other” group that encompasses residual causes.
The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level.
TL;DR: The results show that most cases of liver cancer can be prevented through vaccination, antiviral treatment, safe blood transfusion and injection practices, as well as interventions to reduce excessive alcohol use.
Journal ArticleDOI
Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer.
A. Blythe Ryerson,Christie R. Eheman,Sean F. Altekruse,John W. Ward,Ahmedin Jemal,Recinda L. Sherman,S. Jane Henley,Deborah Holtzman,Andrew C Lake,Anne-Michelle Noone,Robert N. Anderson,Jiemin Ma,Kathleen N. Ly,Kathleen A. Cronin,Lynne Penberthy,Betsy A. Kohler +15 more
TL;DR: The increasing burden of liver and intrahepatic bile duct (liver) cancers is highlighted in this annual report.
Journal ArticleDOI
Global cancer patterns: causes and prevention
Paolo Vineis,Christopher P. Wild +1 more
TL;DR: It is argued that primary prevention is a particularly effective way to fight cancer, with between a third and a half of cancers being preventable on the basis of present knowledge of risk factors.
References
More filters
Journal ArticleDOI
Global cancer statistics
TL;DR: A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
Journal ArticleDOI
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.
TL;DR: The results for 20 world regions are presented, summarizing the global patterns for the eight most common cancers, and striking differences in the patterns of cancer from region to region are observed.
Journal ArticleDOI
Global cancer statistics, 2002.
TL;DR: There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
Journal ArticleDOI
Prevalence and trends in obesity among US adults, 1999-2008.
TL;DR: The increases in the prevalence of obesity previously observed do not appear to be continuing at the same rate over the past 10 years, particularly for women and possibly for men.
Journal ArticleDOI
Global estimates of the prevalence of diabetes for 2010 and 2030.
TL;DR: These predictions, based on a larger number of studies than previous estimates, indicate a growing burden of diabetes, particularly in developing countries.
Related Papers (5)
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet,Sergio Ricci,Vincenzo Mazzaferro,Philip Hilgard,Edward Gane,Jean-Frédéric Blanc,André Cosme de Oliveira,Armando Santoro,Jean-Luc Raoul,Alejandro Forner,Myron Schwartz,Camillo Porta,Stefan Zeuzem,Luigi Bolondi,Tim F. Greten,Peter R. Galle,Jean Francois Seitz,Ivan Borbath,Dieter Häussinger,Tom Giannaris,Minghua Shan,M. Moscovici,D. Voliotis,Jordi Bruix +23 more